Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus (Q30399540)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus (English)

1 reference

Europe PubMed Central

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

7

object named as

James A Roth

1 reference

Europe PubMed Central

21 June 2017

4

object named as

Kelly M Lager

1 reference

Europe PubMed Central

21 June 2017

author name string

Phillip C Gauger

1

1 reference

Europe PubMed Central

21 June 2017

Amy L Vincent

2

1 reference

Europe PubMed Central

21 June 2017

Crystal L Loving

3

1 reference

Europe PubMed Central

21 June 2017

Bruce H Janke

5

1 reference

Europe PubMed Central

21 June 2017

Marcus E Kehrli

6

1 reference

Europe PubMed Central

21 June 2017

language of work or name

0 references

publication date

23 February 2011

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

29

1 reference

Europe PubMed Central

21 June 2017

2712-2719

1 reference

Europe PubMed Central

21 June 2017

15

1 reference

Europe PubMed Central

21 June 2017

Prevalence of swine influenza virus subtypes on swine farms in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Swine influenza viruses a North American perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Isolation and genetic characterization of new reassortant H3N1 swine influenza virus from pigs in the midwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Triple reassortant H3N2 influenza A viruses, Canada, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Evolution of swine H3N2 influenza viruses in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Identification of H2N3 influenza A viruses from swine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Real-time PCR assays to address genetic diversity among strains of Mycoplasma hyopneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Interleukin-8 and the chemokine family.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Further evidence for infection of pigs with human-like H1N1 influenza viruses in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Antibody reactive in antibody‐dependent cell‐mediated cytotoxicity following influenza virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.082

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.01.082

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30399540&oldid=2110450870"